Harbor-UCLA Pediatrics

eLearning Login

Featured Story

Dr. Ruey-Kang Chang's ECG Device Enters Phase II of Development

Dr. Ruey-Kang Chang's medical device company, QT Medical, has entered Phase 2 for development of an ECG device designed for long QT syndrome screening in newborns.

We featured Dr. Chang in our "Faculty Spotlight" in March. In that interview, Dr. Chang said that his device would be "the world's most compact 12-lead ECG system designed for newborn babies." He went on to say that it will probably also be the first ECG system that parents or patients without ECG training can do at home with simple instructions.

It seems others see great potential in the device as well. The National Heart Lung and Blood Institute is funding the project with a budget totaling $1.5 million.